Export

EN
FR
Insulin degludec
Essential medicine status
General description

INN
Insulin degludec
Medicine type
Biological agent
EML status history
Application rejected in 2019 (TRS 1021) for Type 1 diabetes mellitus
Changed in 2021 (TRS 1035) for Type 1 diabetes mellitus
Changed in 2021 (TRS 1035) for Type 2 diabetes mellitus
Therapeutic equivalent for
insulin glargine for Type 1 diabetes mellitus
insulin (analogue, long-acting) for Type 2 diabetes mellitus
insulin (analogue, long-acting) for Type 1 diabetes mellitus
Wikipedia
Insulin degludec
DrugBank
Insulin degludec